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Neuroblastoma (NBL) is the most common extra-cranial
tumour in childhood [1] and commonly presents as an
abdominal mass. Nephroblastoma, also more commonly
known as a Wilms’ tumour, is the commonest renal
tumour in childhood and also typically presents as
abdominal pathology. The natural histories and typical
clinical courses of these tumours are very different, thus
early distinction is important. Both occur in early child-
hood, with Wilms’ having a slightly older peak incidence
at between 3 – 4 years. Histologically, they are different
diseases with NBLs arising from primordial neural crest
cells [1] and Wilms’ being undifferentiated mesodermal
tumours [2]. The heterogeneity of NBLs and their biolo-
gical characteristics mean the prognosis is highly variable;
tumour stage, patient age, tumour oncogenes and DNA
content are all known to be implicated [3]. Wilms’ have
two distinct histopathological types, favorable and unfa-
vorable, with differing outcomes. NBLs are most com-
monly located within the adrenal gland, so typically
present as palpable abdominal masses causing pain and
distension [1,4]. Well described paraneoplastic syn-
dromes include opsomyoclonus and excessive vasoactive
intestinal peptide (VIP) production [1]. Metastatic disease
is common on presentation [1]. Wilms’ usually present as
a large, painless abdominal mass with few constitutional
symptoms [2]. On ultrasound (US), NBLs are solid, het-
erogeneous masses with calcification and are rarely cystic
[4]. With Wilms’, US also evaluates whether the mass is
intra- or extra-renal, solid or cystic, and for the presence
of vascular invasion [2]. MRI effectively assesses the
extent of primary NBL disease, being superior to CT in
assessing metastatic marrow disease, chest wall invasion
and spinal canal involvement. On CT, NBLs are poorly
marginated, heterogeneous masses that can cross the
midline and enter adjacent body cavities. A key-defining
feature is calcification, but this can have a variable
appearance [4]. NBLs tend to encase and displace
structures rather than invade them. Over 90% are
MIBG-sensitive, but for primaries that are not, ⁹⁹mTc-
diphosphonate bone scintigraphy is currently recom-
mended to look for metastatic bony disease [1,3]. MRI
is also useful at Wilms ’ diagnosis, with contrast-
enhanced sequences clearly demonstrating the ‘claw’ of
normal renal tissue around the tumour. Tumours
return low signal on T1W, with variable/high signal inten-
sity on T2W. The non-cystic components typically restrict
on diffusion sequences. In contrast to NBL, vessels are dis-
placed rather than encased and vascular invasion occurs in
approximately 5-10% of cases [4]. NBL staging has evolved
with the simpler International Neuroblastoma Risk Group
(INRG) system [3,5]. Imaging significantly contributes to
this system. To enable consistent reporting, imaging
defined risk factors have been identified by the INRG [3].
Unlike with NBL, chest CT is routinely done for Wilms’
staging. Management strategies for NBL include surgery,
chemotherapy and radiotherapy, with additional myeloa-
blative therapy and recently also immunotherapy for high-
risk disease. A unilateral Wilms’ tumour is treated with
nephrectomy and chemotherapy. With bilateral disease,
pre-operative chemotherapy is vital as each kidney is
staged separately, but the surgical approach is to preserve
normal renal parenchyma.
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